Catalent (CTLT) News Today $59.68 +0.68 (+1.15%) (As of 02:08 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Catalent, Inc. (NYSE:CTLT) is Alpine Associates Management Inc.'s 4th Largest PositionAlpine Associates Management Inc. raised its holdings in Catalent, Inc. (NYSE:CTLT - Free Report) by 3.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,131,126 shares of the company's stock after pNovember 20 at 6:57 AM | marketbeat.comQuest Partners LLC Purchases 36,652 Shares of Catalent, Inc. (NYSE:CTLT)Quest Partners LLC raised its holdings in Catalent, Inc. (NYSE:CTLT - Free Report) by 289.8% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 49,300 shares of the company's stock after acquiring an additional 36,652 shares during the quarter. QuestNovember 18 at 6:59 AM | marketbeat.comCatalent (NYSE:CTLT) Rating Increased to Hold at StockNews.comNovember 18 at 2:01 AM | americanbankingnews.comSumitomo Mitsui Trust Group Inc. Raises Stock Position in Catalent, Inc. (NYSE:CTLT)Sumitomo Mitsui Trust Group Inc. raised its position in Catalent, Inc. (NYSE:CTLT - Free Report) by 3.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 405,318 shares of the company's stock after purchasing an additionalNovember 17, 2024 | marketbeat.comMizuho Markets Americas LLC Takes $30.29 Million Position in Catalent, Inc. (NYSE:CTLT)Mizuho Markets Americas LLC acquired a new position in Catalent, Inc. (NYSE:CTLT - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 500,000 shares of the company's stock, valued at approximately $30,285,000. Mizuho MNovember 16, 2024 | marketbeat.comMichelle R. Ryan Sells 2,800 Shares of Catalent, Inc. (NYSE:CTLT) StockNovember 15, 2024 | insidertrades.comCuri RMB Capital LLC Lowers Position in Catalent, Inc. (NYSE:CTLT)Curi RMB Capital LLC lessened its stake in Catalent, Inc. (NYSE:CTLT - Free Report) by 23.5% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 96,590 shares of the company's stock after selling 29,November 15, 2024 | marketbeat.comJanus Henderson Group PLC's Strategic Reduction in Catalent Inc HoldingsNovember 14, 2024 | gurufocus.comCatalent, Inc. (NYSE:CTLT) Shares Acquired by ING Groep NVING Groep NV increased its stake in shares of Catalent, Inc. (NYSE:CTLT - Free Report) by 162.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,130,504 shares of the company's stock after buying an addNovember 14, 2024 | marketbeat.comEU regulators seek info from rivals, customers in Catalent sale to Novo Holdings - ReutersNovember 14, 2024 | seekingalpha.comEU regulators see info from rivals, customers in Catalent sale to Novo Holdings - ReutersNovember 14, 2024 | seekingalpha.comEU regulators see info from rivals, customers in Catalent's sale to Novo HoldingsNovember 14, 2024 | msn.comStockNews.com Upgrades Catalent (NYSE:CTLT) to "Hold"StockNews.com upgraded shares of Catalent from a "sell" rating to a "hold" rating in a report on Thursday.November 14, 2024 | marketbeat.comCapital World Investors Expands Stake in Catalent IncNovember 13, 2024 | gurufocus.comEU regulators quiz Novo Nordisk, Catalent rivals on $16.5 bln dealNovember 13, 2024 | reuters.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Catalent (CTLT), Moderna (MRNA) and HCA Healthcare (HCA)November 8, 2024 | markets.businessinsider.comVan ECK Associates Corp Raises Position in Catalent, Inc. (NYSE:CTLT)Van ECK Associates Corp lifted its stake in Catalent, Inc. (NYSE:CTLT - Free Report) by 47.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 124,424 shares of the company's stock after buying an additional 39,983 shNovember 8, 2024 | marketbeat.comCatalent’s Biologics Underperformance and PCH Stability Lead to Hold RatingNovember 7, 2024 | markets.businessinsider.comOlympiad Research LP Purchases 15,924 Shares of Catalent, Inc. (NYSE:CTLT)Olympiad Research LP boosted its position in Catalent, Inc. (NYSE:CTLT - Free Report) by 93.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,009 shares of the company's stock after buying an additionNovember 7, 2024 | marketbeat.comCatalent Inc Reports Q1 Fiscal 2025 Earnings: $1.02 Billion Revenue, $(0.71) EPSNovember 7, 2024 | gurufocus.comCatalent, Inc. (NYSE:CTLT) Given Consensus Rating of "Hold" by BrokeragesCatalent, Inc. (NYSE:CTLT - Get Free Report) has been assigned an average recommendation of "Hold" from the eight research firms that are covering the company, MarketBeat.com reports. Eight investment analysts have rated the stock with a hold recommendation. The average 12 month target price amongNovember 7, 2024 | marketbeat.comCatalent Inc. Reports Q1 Fiscal 2025 ResultsNovember 6, 2024 | markets.businessinsider.comEU Antitrust Regulators to Rule on Novo's Catalent Buy by Dec. 6November 5, 2024 | msn.comNovo Holdings planned $16.5B planned acquisitions of Catalent gets EU inquiryNovember 5, 2024 | msn.comCatalent Inc. Q1 Loss NarrowsNovember 5, 2024 | markets.businessinsider.comCatalent reports Q1 EPS (13c), consensus 5cNovember 5, 2024 | markets.businessinsider.comCatalent reports Q1 loss, misses market expectationsNovember 5, 2024 | msn.comCatalent misses Q1 revenue estimates ahead of $16.5 bln deal close with Novo HoldingsNovember 5, 2024 | reuters.comCatalent, Inc. (NYSE:CTLT) Shares Sold by New York State Teachers Retirement SystemNew York State Teachers Retirement System trimmed its holdings in Catalent, Inc. (NYSE:CTLT - Free Report) by 5.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 145,558 shares of the company's stock after selling 8,746 shNovember 4, 2024 | marketbeat.comAssenagon Asset Management S.A. Has $330,000 Position in Catalent, Inc. (NYSE:CTLT)Assenagon Asset Management S.A. decreased its position in shares of Catalent, Inc. (NYSE:CTLT - Free Report) by 84.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,450 shares of the company's stock after selling 28,552 sNovember 4, 2024 | marketbeat.comEU antitrust regulators to decide on Novo's Catalent buy by Dec. 6November 4, 2024 | reuters.comAmericana Partners LLC Takes Position in Catalent, Inc. (NYSE:CTLT)Americana Partners LLC acquired a new position in Catalent, Inc. (NYSE:CTLT - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 9,736 shares of the company's stock, valued at approximatNovember 2, 2024 | marketbeat.comNorris Perne & French LLP MI Lowers Stock Position in Catalent, Inc. (NYSE:CTLT)Norris Perne & French LLP MI lowered its holdings in shares of Catalent, Inc. (NYSE:CTLT - Free Report) by 10.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 274,761 shares of the company's stock after selNovember 1, 2024 | marketbeat.comCatalent to sell New Jersey drug facility to ArdenaOctober 31, 2024 | finance.yahoo.comBacklash builds against Novo’s Catalent takeoverOctober 31, 2024 | finance.yahoo.comForsta AP Fonden Grows Position in Catalent, Inc. (NYSE:CTLT)Forsta AP Fonden increased its stake in shares of Catalent, Inc. (NYSE:CTLT - Free Report) by 106.1% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 36,900 shares of the company's stock after acquiring an additional 19,000 shares duringOctober 31, 2024 | marketbeat.comWhat to Expect From Catalent's Next Quarterly Earnings ReportOctober 29, 2024 | msn.comLegacy Capital Group California Inc. Purchases New Position in Catalent, Inc. (NYSE:CTLT)Legacy Capital Group California Inc. acquired a new position in Catalent, Inc. (NYSE:CTLT - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 9,631 shares of the company's stock, valued at appOctober 25, 2024 | marketbeat.comRoche comes out against allowing takeover of drug manufacturer CatalentOctober 23, 2024 | investing.comRoche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent AcquisitionOctober 23, 2024 | benzinga.comRoche CEO says antitrust regulators should block Catalent sale to Novo Holdings (update)October 23, 2024 | msn.comRoche comes out against clearing takeover of drug manufacturer CatalentOctober 23, 2024 | reuters.comJoseph Anthony Ferraro Sells 320 Shares of Catalent, Inc. (NYSE:CTLT) StockOctober 22, 2024 | insidertrades.comCatalent, Inc. (NYSE:CTLT) SVP Joseph Anthony Ferraro Sells 320 SharesCatalent, Inc. (NYSE:CTLT - Get Free Report) SVP Joseph Anthony Ferraro sold 320 shares of the stock in a transaction on Friday, October 18th. The stock was sold at an average price of $59.97, for a total transaction of $19,190.40. Following the sale, the senior vice president now owns 23,967 shares of the company's stock, valued at approximately $1,437,300.99. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.October 21, 2024 | marketbeat.comCatalent Issues Open Letter To Customers; To Operate As Full-service CDMO Under NovoOctober 21, 2024 | markets.businessinsider.comCatalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo HoldingsOctober 21, 2024 | finance.yahoo.comCatalent’s Maselli to continue as CEO post Novo Holdings deal closeOctober 21, 2024 | msn.comCatalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyoutOctober 21, 2024 | reuters.comAfter US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of CatalentOctober 19, 2024 | msn.comMinnesota firm acquires North Carolina lab from CatalentOctober 17, 2024 | bizjournals.com Get Catalent News Delivered to You Automatically Sign up to receive the latest news and ratings for CTLT and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] CTLT Media Mentions By Week CTLT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTLT News Sentiment▼0.670.47▲Average Medical News Sentiment CTLT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTLT Articles This Week▼106▲CTLT Articles Average Week Get Catalent News Delivered to You Automatically Sign up to receive the latest news and ratings for CTLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News BioNTech News Teva Pharmaceutical Industries News BeiGene News Viatris News Moderna News Summit Therapeutics News Genmab A/S News Dr. Reddy's Laboratories News Vaxcyte News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CTLT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catalent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTLT Stock Alerts